The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A System...
The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis
About this item
Full title
Author / Creator
Hu, Suiyuan , Lin, Chu , Cai, Xiaoling , Zhu, Xingyun , Lv, Fang , Nie, Lin and Ji, Linong
Publisher
United States: Hindawi
Journal title
Language
English
Formats
Publication information
Publisher
United States: Hindawi
Subjects
More information
Scope and Contents
Contents
Objective. To assess the association between the use of biological disease-modifying antirheumatic drugs (bDMARDs) and the risk of cardiovascular events in patients with systemic inflammatory conditions. Methods. Eligible cohort studies or randomized controlled trials (RCTs) from inception to January 2021 were included. Pooled odds ratios (ORs) wit...
Alternative Titles
Full title
The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a8f799f371644ba49536f14bdac369ba
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a8f799f371644ba49536f14bdac369ba
Other Identifiers
ISSN
0962-9351
E-ISSN
1466-1861
DOI
10.1155/2021/7712587
